T Cell

T-cells are a critical component of the adaptive immune system and are indispensable in protecting humans from pathogenic infections.
Adoptive T Cell Therapy Methodology

Adoptive T cell therapy is a type of immunotherapy with the ability to target cancer cells through inherent mechanisms of the immune system. The method works by infusing tumor-specific cytotoxic T cells into patients which will recognize, target and attack tumor cells.

Read More

Overview

Latest T Cell News and Research

Researchers identify key protein required for optimal immune responses to cancer

Researchers identify key protein required for optimal immune responses to cancer

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

CanSino's potential coronavirus vaccine triggers immune response in clinical trial

CanSino's potential coronavirus vaccine triggers immune response in clinical trial

Many different T cell receptors recognize SARS-CoV-2 antigenic sites

Many different T cell receptors recognize SARS-CoV-2 antigenic sites

First COVID-19 vaccine found to be safe, able to generate rapid immune response in phase 1 clinical trial

First COVID-19 vaccine found to be safe, able to generate rapid immune response in phase 1 clinical trial

Different immune responses can occur in Covid-19, shows study

Different immune responses can occur in Covid-19, shows study

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

Lattice light-sheet microscopy could help in drug and vaccine development

Lattice light-sheet microscopy could help in drug and vaccine development

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Chasing the elusive dream of a COVID cure

Chasing the elusive dream of a COVID cure

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

Does HIV infection increase the severity of COVID-19?

Does HIV infection increase the severity of COVID-19?

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia